FILE:CVS/CVS-8K-20040909200111.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Item 8.01     Other Events
     
On September 9, 2004, CVS Corporation announced the pricing of $1.2 billion private placement of unsecured 5 & 10-year senior notes . A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01     Exhibits
     
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WOONSOCKET, R.I.
-
September 9, 2004
-
CVS Corporation (NYSE: CVS) announced today that it privately placed $650 million aggregate principal amount of 4.00% unsecured senior notes due 2009 with an original issue price of 99.735% and $550 million aggregate principal amount of 4.875% unsecured senior notes due 2014 with an original issue price of 99.142% The notes will be general unsecured obligations of CVS Corporation and will rank equally in right of payment with all other unsecured and unsubordinated debt of the Company. The offering is expected to close on or about September 14, 2004. The Company intends to use the net proceeds of the offering to repay commercial paper issued to finance the acquisition of approximately 1,260 Eckerd drugstores, as well as Eckerd Health Services, which includes Eckerd's pharmacy benefits management and mail order businesses, from J.C. Penney Company Inc.
This announcement is neither an offer to sell nor a solicitation to buy any of these securities. The notes have not been registered under the Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements of the Securities Act.
 


